loader
Please Wait
Applying Filters...

Suanfarma Suanfarma

X

Technical details about Ethyl Loflazepate, learn more about the structure, uses, toxicity, action, side effects and more

Client Email Product
Menu
2D Structure
1. Also known as: Victan, Meilax, 29177-84-2, Ethyl fluclozepate, Cm 6912, Loflazepic acid, ethyl ester
Molecular Formula
C18H14ClFN2O3
Molecular Weight
360.8  g/mol
InChI Key
CUCHJCMWNFEYOM-UHFFFAOYSA-N
FDA UNII
VJB5FW9W9J

1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
ethyl 7-chloro-5-(2-fluorophenyl)-2-oxo-1,3-dihydro-1,4-benzodiazepine-3-carboxylate
2.1.2 InChI
InChI=1S/C18H14ClFN2O3/c1-2-25-18(24)16-17(23)21-14-8-7-10(19)9-12(14)15(22-16)11-5-3-4-6-13(11)20/h3-9,16H,2H2,1H3,(H,21,23)
2.1.3 InChI Key
CUCHJCMWNFEYOM-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CCOC(=O)C1C(=O)NC2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3F
2.2 Other Identifiers
2.2.1 UNII
VJB5FW9W9J
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Cm 6912

2. Ethyl Flucozepate

3. Victan

2.3.2 Depositor-Supplied Synonyms

1. Victan

2. Meilax

3. 29177-84-2

4. Ethyl Fluclozepate

5. Cm 6912

6. Loflazepic Acid, Ethyl Ester

7. Vjb5fw9w9j

8. Ethyl 7-chloro-5-(o-fluorophenyl)-2,3-dihydro-2-oxo-1h-1,4-benzodiazepine-3-carboxylate

9. 1h-1,4-benzodiazepine-3-carboxylic Acid, 7-chloro-5-(2-fluorophenyl)-2,3-dihydro-2-oxo-, Ethyl Ester

10. Ethylis Loflazepas

11. Ethyl Loflazepate [inn:jan]

12. Loflazepate D'ethyle

13. Loflazepato De Etilo

14. Ethylis Loflazepas [inn-latin]

15. Loflazepate D'ethyle [inn-french]

16. Loflazepato De Etilo [inn-spanish]

17. Einecs 249-489-4

18. Unii-vjb5fw9w9j

19. Brn 0765264

20. Dea No. 2758

21. Meilax (tn)

22. Cm-6912

23. Ethyl 7-chloro-5-(2-fluorophenyl)-2-oxo-1,3-dihydro-1,4-benzodiazepine-3-carboxylate

24. 5-25-08-00124 (beilstein Handbook Reference)

25. Ethyl Loflazepate (jan/inn)

26. Schembl156702

27. Ethyl Loflazepate [mi]

28. Ethyl Loflazepate [inn]

29. Ethyl Loflazepate [jan]

30. Chembl1213460

31. Chebi:31573

32. Dtxsid60865475

33. Ethyl Loflazepate [mart.]

34. Ethyl Loflazepate [who-dd]

35. Db01545

36. Ethyl 7-chloro-5-(2-fluorophenyl)-2-oxo-2,3-dihydro-1h-1,4-benzodiazepine-3-carboxylate

37. D01293

38. Q5404460

39. Ethyl 7-chloro-5-(2-fluorophenyl)-2-oxo-2,3-dihydro-1h-1,4-benzodiazepine-3-carboxylate #

40. (e)-ethyl 7-chloro-5-(2-fluorophenyl)-2-oxo-2,3-dihydro-1h-benzo[e][1,4]diazepine-3-carboxylate

41. Ethyl 7-chloro-5-(2-fluorophenyl)-2-oxo-2,3-dihydro-1h-benzo[e][1,4]diazepine-3-carboxylate

2.4 Create Date
2005-03-25
3 Chemical and Physical Properties
Molecular Weight 360.8 g/mol
Molecular Formula C18H14ClFN2O3
XLogP32.9
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count5
Rotatable Bond Count4
Exact Mass360.0676982 g/mol
Monoisotopic Mass360.0676982 g/mol
Topological Polar Surface Area67.8 Ų
Heavy Atom Count25
Formal Charge0
Complexity556
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count1
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Anti-Anxiety Agents

Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. (See all compounds classified as Anti-Anxiety Agents.)


4.2 ATC Code

N - Nervous system

N05 - Psycholeptics

N05B - Anxiolytics

N05BA - Benzodiazepine derivatives

N05BA18 - Ethyl loflazepate


Post Enquiry
POST ENQUIRY